ProfileGDS5822 / ILMN_1242047
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 97% 97% 95% 95% 95% 97% 96% 95% 98% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 11954.497
GSM1276600PDAC Late Ablation Control 22149.297
GSM1276601PDAC Late Ablation Control 31404.695
GSM1276602PDAC Late Ablation 11156.595
GSM1276603PDAC Late Ablation 21180.895
GSM1276604PDAC Late Ablation 32754.697
GSM1303940PDAC Late Ablation_anti-CTLA4 11532.496
GSM1303941PDAC Late Ablation_anti-CTLA4 21277.595
GSM1303942PDAC Late Ablation_anti-CTLA4 33160.898